Term
| how long are schedule II drug records kept for |
|
Definition
|
|
Term
| How long are all other records kept for |
|
Definition
|
|
Term
| how many control schedules are there |
|
Definition
|
|
Term
|
Definition
| Each drug has a high potential for abuse and no accepted medical use in the U.S |
|
|
Term
|
Definition
| Has a high potential for abuse and may lead to physical or psychological dependence but also has a currently accepted medical use in the u.s. EX: Amphetamines,opium,cocaine, methadone |
|
|
Term
|
Definition
| drugs potential for abuse is less than those in 1 and 2 and there is currently accepted medical use in U.S but abuse may lead to moderate or low physical dependence or high psychological dependence. EX: anabolic steroids, and various compounds containing limited quantities of narcotic substances such as codeine |
|
|
Term
|
Definition
| Has a low potential for abuse relative to schedule 3 drugs and there is currently accepted medical use in the U.S but abuse may lead to limited physical dependence or psychological dependence EX: Phenobarbital, the sedative chloral hydrate, and the anesthetic methohexital |
|
|
Term
|
Definition
| low potential for abuse relative to schedule 4 drugs. compounds contaning limited amounts of a narcotic such as codeine |
|
|
Term
| Where are Schedule 2 drugs usually kept |
|
Definition
| Generally stored in a locked, tamper-proof narcotics cabinate |
|
|
Term
|
Definition
| Used to order C-I and C-II substances |
|
|
Term
|
Definition
| report of theft or loss of controlled substances |
|
|
Term
|
Definition
| FDA maintained which encourages health care professionals to report adverse effects that occur from the use of and approved drug or other medical products |
|
|
Term
|
Definition
| an unintended side effect of a medication that is negative in some way injurious to a patients health |
|
|
Term
|
Definition
| the action taken to remove a drug from the market and have it returned to the manufacturer |
|
|
Term
| how many classes of recalls are there and what is the most serious |
|
Definition
|
|
Term
|
Definition
| where there is a strong likelihood that the product will cause serious adverse effects or death |
|
|
Term
|
Definition
| the product may cause temporary but reversible adverse effects, or in which there is little likelihood of serious adverse effects |
|
|
Term
|
Definition
| Where a product is not likely to cause adverse effects |
|
|
Term
|
Definition
| an independent non-profit organization that establishes standards and monitors compliance for nearly twenty thousand health care programs in the U.S |
|
|
Term
|
Definition
| specific guidelines for practice |
|
|
Term
| Before a drug can be marketed |
|
Definition
| It must be shown through testing that it is safe and effective for its intended use. |
|
|
Term
|
Definition
|
|
Term
| What is the area of greatest emplyment |
|
Definition
|
|
Term
| where dose digitalis come from and what is is most commonly used to treat |
|
Definition
| The foxglove plant and treating hear disease |
|
|
Term
| What is the Human Genome project |
|
Definition
| an attempt to map the entire DNA sequence in the human genome. |
|
|
Term
|
Definition
| The study of drugs-their properties, uses, application, and effects |
|
|
Term
|
Definition
| the study of physical, chemical, biochemical, and biological properties of drugs as well as the search for new drugs from natural sources |
|
|
Term
|
Definition
| an authoritative listing of drugs and issues relating to their use |
|
|
Term
|
Definition
| of or about drugs; also, a drug product. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| a substance that acts against a toxin in the body; also a vaccine containing antitoxins, used to fight disease |
|
|
Term
|
Definition
| a substance which harms or kills microorganisms like bacteria and fungi |
|
|
Term
|
Definition
| chemical produced by the body that regulate body functions and proceses |
|
|
Term
| 1970 controlled substance act(CSA) |
|
Definition
| The CSA classifies five levels of drugs (controlled substances) that have potential for abuse and therefore restricts their distribution |
|
|
Term
| 1970 poison prevention packaging act |
|
Definition
| requires child-proof packaging on all controlled and most prescription drugs |
|
|
Term
| 1938 Food, Drug and cosmetic (FDC) Act |
|
Definition
| in response to the fatal poisoning of 107 people. This comprehensive law requires new drug be shown to be safe before marketing |
|
|
Term
| 1951 Durham-Humphrey Amendment |
|
Definition
| This law defines what drugs require a prescription by a licensed practitioner and require the legend on its label |
|
|
Term
|
Definition
| any drug which requires a prescription and either of these "legends" on the label: "Caution Federal law prohibits dispensing without a prescription," or "Rx only" |
|
|
Term
|
Definition
| 20-100 patients, time:several months, purpose:mainly safety |
|
|
Term
|
Definition
| up to several hundred patients, time:several months to two years, purpose:short-term safety but mainly effectiveness |
|
|
Term
|
Definition
| several hundred to several thousand patients, time: one to four years, purpose:safety, dosage, and effectiveness |
|
|
Term
| How long is a drug patent in effect for |
|
Definition
| 17 years from the date of the drugs discovery |
|
|
Term
|
Definition
| To provide up to five year extensions of patent protection to the paten holders to make up for time lost while products went through the FDA approval process |
|
|
Term
| Pharmaceutical equivalent |
|
Definition
| drug products that contain identical amounts of the same active ingredients in the same dosage form |
|
|
Term
|
Definition
| pharmaceutical equivalents that produce the same effects in patients |
|
|
Term
|
Definition
| important associated information that is not on the label of a drug product itself, but is provided with the product in the form of an insert, brochure, or other document |
|
|
Term
| Combat Methamphetamine Epidemic Act |
|
Definition
| sets daily and monthly restrictions (3.6 grams per day and 7.5 grams per month) |
|
|
Term
|
Definition
| Medications with habit-forming ingredients that could be dispensed by a pharmacist without a prescription to a person at least 18 years old |
|
|
Term
| What dose Each Set of NDC Numbers indicate |
|
Definition
| First Set: Manufacturer Second set: Indicates the medication, its strength, and dosage form Third Set: indicated package size |
|
|
Term
| Controlled substance mark |
|
Definition
| the mark which indicated the control category of a drug with a potential for abuse |
|
|
Term
| minimum requirements on prescription labels for most drugs |
|
Definition
| name and address of dispenser, prescription serial number, date of prescription or filing, expiration date, name of prescriber |
|
|
Term
|
Definition
| the blood pressure as the heart is pumping blood into the cardiovascular system |
|
|
Term
|
Definition
| the blood pressure after the heart has completed a pumping stroke |
|
|
Term
|
Definition
| a system of glands that secret hormones into the bloodstream |
|
|
Term
|
Definition
| the organs from the mouth to the anus. The GI tract use a portion of the alimentary tract |
|
|
Term
|
Definition
| The body covering, i.e, skin, hair, and nails |
|
|
Term
|
Definition
| a type of white blood cells that helps the body defend itself against bacteria and diseased cells |
|
|
Term
| What dose the axial skeleton include |
|
Definition
| Skull and the vertebra surrounding the spinal column |
|
|
Term
|
Definition
| a part of the lungs where gases are exchanged between blood and the air |
|
|
Term
|
Definition
| the functional unit of the kidney responsible for removing wastes from the blood and producing urine |
|
|
Term
| extemporaneous compounding |
|
Definition
| the on-demand preparation of a drug product according to a physicians prescription, formula, or recipe |
|
|
Term
| what dose unit dose packaging usually contain |
|
Definition
| they often contain only the name, strength, manufacture, lot number, expiration date, and dosage form |
|
|
Term
|
Definition
| when drug activity is at the site of administration |
|
|
Term
|
Definition
| when a drug is introduced into the venous (circulatory) system and carried to the site of activity |
|
|
Term
|
Definition
| refers to anything involving the alimentary tract i.e. from the mouth to the tectum |
|
|
Term
| What are the 4 enteral routes of administration |
|
Definition
| oral, sublingual, buccal, and rectal |
|
|
Term
|
Definition
| refers to any sites of administration that are outside of or beside the alimentary tract |
|
|
Term
| what are the 7 routes or parenteral administration |
|
Definition
| intraocular, intranasal, inhalation, intravenous, intramuscular, intradermal, and dermal |
|
|
Term
|
Definition
| the breaking apart of a tablet into smaller pieces |
|
|
Term
|
Definition
| when the smaller pieces of a disintegrated tablet dissole in solution |
|
|
Term
|
Definition
| a clear liquid made up of one or more ingredients dissolved in a solvent |
|
|
Term
|
Definition
| a liquid that can dissolve another substance to form a solution |
|
|
Term
|
Definition
| mixture of two liquids that do not mix with each other in which one liquid is dispersed through the other by using a stabilizer called an emulsifier |
|
|
Term
|
Definition
| are formulations in which the drug dose not completely dissolve in the solvent |
|
|
Term
|
Definition
| a sterile condition is one which is free of all microorganisms, both harmful and harmless |
|
|
Term
|
Definition
| ingredients in a formulation designed to control pH |
|
|
Term
|
Definition
| a solvent that dissolves a freeze dried powder or dilutes a solution |
|
|
Term
|
Definition
| not irritating: does not promote infection or abscess |
|
|
Term
|
Definition
| the absorption of drugs through the skin, often a systemic effect |
|
|
Term
|
Definition
| (e.g. suppositories, tablets, solutions) most often used for local effect. however long term systemic effects can be achieved with IUD |
|
|
Term
|
Definition
| vary from gels and lotions aerosols, ointments, and pastes. Transdermal patches are also common dosage form |
|
|
Term
|
Definition
| deliver drugs to the lungs. MDI aerosols, dry powder inhalers, and nebulizers are common devises used to administer drugs through this route |
|
|
Term
| Intranasal administration |
|
Definition
| of some drugs produce blood concentrations similar to where the drug is intravenously administered |
|
|
Term
| intradermal administration |
|
Definition
| used for diagnostics, desensitization, and immunization |
|
|
Term
|
Definition
| can be used for both short term and long term therapies. insulin is the most important drug routinely administered by this route |
|
|
Term
|
Definition
| generally result in lower but longer lasting blood concentrations than with intravenous administration |
|
|
Term
|
Definition
| techniques or methods that maintain the sterile condition of products |
|
|
Term
|
Definition
| Chemicals produced by microorganisms that can cause pyretic(fever) reactions in patients |
|
|
Term
|
Definition
| a characteristic of a solution determined by the number of dissolved particles in it |
|
|
Term
|
Definition
| when a solution has an osmolarity equivalent to that of blood |
|
|
Term
|
Definition
| solution has greater osmolarity than blood |
|
|
Term
|
Definition
| when a solution has a lesser osmolarity than blood |
|
|
Term
| Large Volume Parental Solutions (LVP) |
|
Definition
| are intravenous solutions packaged in containers holding 100ml or more |
|
|
Term
| what are common uses of LVP solutions without aditives |
|
Definition
| include correction of electrolyte and fluid balance disturbances, nutrition, and vehicles for a administering other drugs |
|
|
Term
| Compound sterile preparation |
|
Definition
| a compounded sterile parenteral dosage form that will be parenterally administered |
|
|
Term
|
Definition
| provides guidelines for the development and implication of essential policies and procedures for the safe preparation of CSPs |
|
|
Term
| Small volume parental solutions (SVP) |
|
Definition
| are usually packaged products that are either directly administered to a patient or added to another parenteral formulation |
|
|
Term
|
Definition
| a drug that is added to a parenteral solution |
|
|
Term
|
Definition
| the resulting solution when a drug is added to a parenteral solution |
|
|
Term
|
Definition
| a specially designed mini bag where a drug is put into the SVP just prior to administration. |
|
|
Term
| Total parenteral nutrition solution (TPN) |
|
Definition
| complex solutions with two base solutions (amino acids and dextrose) and additional micro-nutrients |
|
|
Term
| Total nutrient admixture solution (TNA) |
|
Definition
| a TPN solution that contains intravenous fat emulsion |
|
|
Term
| a TPN solution that contains intravenous fat emulsion |
|
Definition
|
|
Term
| Peritoneal dialysis solution |
|
Definition
| a solution placed in and emptied from the peritoneal cavity to remove toxic substances |
|
|
Term
|
Definition
| large volume splash solutions used during surgical or urologic procedures to bathe and moisten body tissue |
|
|
Term
|
Definition
| the action in which a drug in a higher concentration solution passes through a permeable membrane to a lower concentration solution |
|
|
Term
|
Definition
| movement of particles in a solution through permeable membranes |
|
|
Term
| what are the parts of a needle |
|
Definition
| hub,shaft,bevel, and lume |
|
|
Term
|
Definition
| the part of the needle that attaches to the syringe |
|
|
Term
|
Definition
| the stem of the needle that provides the overall length of the needle |
|
|
Term
|
Definition
| an angled surface at the tip of a needle |
|
|
Term
|
Definition
| a measurement with needles: the higher the gauge, the smaller the lumen |
|
|
Term
|
Definition
| the hollow center of a needle |
|
|
Term
|
Definition
| a filter that can filter solutions being drawn into or expelled from a syringe but not both ways in the same precedure |
|
|
Term
|
Definition
| a filter that filters solution as the solution is expelled from the syringe |
|
|
Term
|
Definition
| a filter placed immediately before a solution enters a patients vein |
|
|
Term
|
Definition
| the rate at which the solution is administered to the patient |
|
|
Term
|
Definition
| small volume solutions connected to an LVP |
|
|
Term
|
Definition
| an administration device used when a primary LVP solution is not available |
|
|
Term
|
Definition
| regulations require that every parenteral compounding facility to have a quality assurance program |
|
|
Term
|
Definition
| regulations from USP/NF pertaining to the nonsterile compounding of formulations |
|
|
Term
|
Definition
| regulations from USP/NF pertaining to the sterile compounding of formulations |
|
|
Term
|
Definition
| formulas and procedures for what should happen when a formulation is compounded |
|
|
Term
|
Definition
| a record of what actually happened when the formulation was compounded |
|
|
Term
|
Definition
| required on commercially manufactured products and are determined after extensive study of products stability |
|
|
Term
|
Definition
| used for compounded preparations only |
|
|
Term
| What is the minimum weighable quantity a Class A balance can have |
|
Definition
|
|
Term
| What is the maximum weighable quantity a Class A balance can have |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| to set mark or check the graduations of a measuring devise |
|
|
Term
|
Definition
| the amount of weight that will move the balance pointer one division mark on the marker plate |
|
|
Term
|
Definition
| the process of grinding powders to reduce particle size |
|
|
Term
| what side should the material to be weighed be on |
|
Definition
|
|
Term
| what side should the weights be placed on |
|
Definition
|
|
Term
| what is the preferred pipet for compounding |
|
Definition
|
|
Term
|
Definition
| a technique for mixing two powders of unequal quantity |
|
|
Term
|
Definition
| triturating a powder drug with a solvent in which it is insoluble to reduce its particle size |
|
|
Term
|
Definition
| electrolytes used in the preparation of suspensions to form particles that can be easily redispersed |
|
|
Term
|
Definition
| an ingredient used in the preparation of suspensions to increase the viscosity of the liquid |
|
|
Term
|
Definition
|
|
Term
|
Definition
| a stabilizing agent in emulsions |
|
|
Term
|
Definition
| an emulsion in which water is dispersed through an oil base |
|
|
Term
|
Definition
| an emulsion in which oil is dispersed through a water base |
|
|
Term
|
Definition
| a stabilizing agent for water based dispersion mediums |
|
|
Term
|
Definition
| a stabilizing agent for oil based dispersion mediums |
|
|
Term
| what is the continental method |
|
Definition
| one of the methods for preparing emulsions. also known as the Dry Gum Method |
|
|
Term
| What is the Wet Gum Method |
|
Definition
|
|
Term
|
Definition
| the initial emulsion to which ingredients are added to create the final product |
|
|
Term
|
Definition
| a method of making suppositories in which the ingredients are compressed in a mold |
|
|
Term
|
Definition
| a suppository preparation method in which the active ingredients are dispersed or dissolved in a melted suppository base |
|
|
Term
| what is the objective of Drug Therapy |
|
Definition
| to deliver the right drug in the right concentration to the right site of action, and at the right time to produce the desired effect |
|
|
Term
|
Definition
| the location where and administered drug produces and effect |
|
|
Term
|
Definition
| the cellular material located at the site of action that interacts with the drug |
|
|
Term
|
Definition
| the characteristic of a drug that makes its action specific to certain receptors and tissues |
|
|
Term
|
Definition
| drugs that activate receptors to accelerate or slow normal cellular function |
|
|
Term
|
Definition
| drugs that bind with receptors but do not activate them. they block receptor action by preventing other drugs or substances from activating them |
|
|
Term
|
Definition
| the study of the factors associated with drug products and physiological processes and the resulting systemic concentrations of drugs |
|
|
Term
| minimum effective concentration (MEC) |
|
Definition
| the blood concentration needed for a drug to produce a response |
|
|
Term
|
Definition
| the time MEC is reached and the response occurs |
|
|
Term
|
Definition
| a drugs blood concentration range between its MEC and MTC |
|
|
Term
| minimum toxic concentration (MTC) |
|
Definition
| the upper limit of the therapeutic window. Drug concentrations above the MTC increase the risk of undesired effects |
|
|
Term
|
Definition
| the time drug concentration is above the MEC |
|
|
Term
|
Definition
| absorption, distribution, metabolism, and excretion |
|
|
Term
|
Definition
| the amount of time it takes for the blood concentration of a drug to decline one-half an initial value |
|
|
Term
|
Definition
| a term sometimes used to refer to all of the ADME processes together |
|
|
Term
|
Definition
| the processes of metabolism and excretion |
|
|
Term
|
Definition
| are more lipid soluble and penetrate biological membranes more easily than ionized drugs |
|
|
Term
|
Definition
| associate with water molecules, creating larger particles with reduced penetrating capability |
|
|
Term
|
Definition
| the movement of drugs from an area of higher concentration to lower concentration |
|
|
Term
|
Definition
| the movement of drugs from an area of lower concentration to an area of higher concentration |
|
|
Term
|
Definition
| the movement of a drug from the dosage formulation to the blood |
|
|
Term
|
Definition
| the time a drug will stay in the stomach before it is emptied into the small intestine |
|
|
Term
|
Definition
| the attachment of a drug molecule to a plasma or tissue protein, effectively making the drug inactive but also keeping it within the body |
|
|
Term
|
Definition
| the substance resulting from the bodies transformation of an administered drug |
|
|
Term
|
Definition
| a complex protein that catalyzes chemical reactions |
|
|
Term
|
Definition
| the increase in hepatic enzyme activity that results in greater metabolism of drugs |
|
|
Term
|
Definition
| the decrease in hepatic enzyme activity that results in reduced metabolism of drugs |
|
|
Term
|
Definition
| the transfer of drugs and their metabolites from the liver to the bile in the gallbladder then into the intestine and then back into circulation |
|
|
Term
|
Definition
| the substance degradation of an orally administered drug caused by enzyme metabolism in the liver before the drug reaches the systemic circulation |
|
|
Term
| pharmaceutical equivalent |
|
Definition
| drug products that contain identical amounts of the same active ingredient in the same dosage form |
|
|
Term
| pharmaceutical alternative |
|
Definition
| drug products that contain the same ACTIVE INGREDIENTS but not necessarily in the same salt form, amount, or dosage form |
|
|
Term
|
Definition
| pharmaceutical equivalents that produce the same effects in patients |
|
|
Term
|
Definition
| the relative amount of an administered dose that reaches the general circulation and the rate at which this occurs |
|
|
Term
|
Definition
| the comparison of bioavailability btwn two dosage forms |
|
|
Term
|
Definition
| a field of study which defines the hereditary basis of individual distribution metabolism and excretion |
|
|
Term
|
Definition
| an unintended side effect of a medication that is negative or in some way injurous to a patients health |
|
|
Term
|
Definition
| an abnormal sensitivity generally resulting in an allergic reaction |
|
|
Term
|
Definition
| an unexpected reaction the first time a drug is taken generally due to genetic causes |
|
|
Term
|
Definition
| the ability of a substance to cause cancer |
|
|
Term
|
Definition
| when two different molecules associate or attach to each other |
|
|
Term
|
Definition
| a drug that is bound to a plasma protein is removed when another drug of greater binding potential binds to the same protein |
|
|
Term
|
Definition
| the summation in effect when two drugs with similar pharmacological actions are taken |
|
|
Term
|
Definition
| when two drugs with similar pharmacological actions produce greater effects than the sum of individual effects |
|
|
Term
|
Definition
| when one drug with no inherent activity of its own increases the activity of another drug that produces an effect |
|
|
Term
|
Definition
| original reports of clinical and other types of research projects and studies |
|
|
Term
|
Definition
| general reference works based upon primary literature sources |
|
|
Term
|
Definition
| condensed works based on primary literature such as textbooks,monographs,etc |
|
|
Term
| Drug Facts and Comparisons |
|
Definition
| used to compare medications in the same therapeutic class |
|
|
Term
| Martindale, The Complete Drug Reference |
|
Definition
| Used to research foreign drugs |
|
|
Term
|
Definition
| Used when investigating off label medication indications |
|
|
Term
| Handbook on Injectable Drugs |
|
Definition
| includes info on preparation, storage, administration, compatibility, and drug stability of injectable drugs |
|
|
Term
|
Definition
| provides the latest pricing information, including nationally recognized AWP's and suggested retail prices for OTC products |
|
|
Term
|
Definition
| the common name for the FDA's Approved Drug Products with Therapeutic Equivalence |
|
|
Term
| In the Orange Book what dose Code A stand for |
|
Definition
| are considered equivalent |
|
|
Term
| In the Orange Book what dose Code B stand for |
|
Definition
| Documented as nonequivalent |
|
|
Term
|
Definition
| Use this reference to find trade and generic names |
|
|
Term
|
Definition
| Use when information on chemical attributes of drugs is needed |
|
|
Term
| Physicians Desk Reference |
|
Definition
| the info is similar the pharmaceutical manufactures drug package inserts since manufactures prepare the essential drug info found in the PDR |
|
|
Term
| How often is Remington published |
|
Definition
|
|
Term
|
Definition
| a list of medications approved for use |
|
|
Term
|
Definition
| a system that allows a pharmacy to use an prescribed medications |
|
|
Term
|
Definition
| a limited list of approved medications |
|
|
Term
|
Definition
| pharmaceutical equivalents that produce the same effects in patients |
|
|
Term
|
Definition
| a system that maintains a continuous record of every item in inventory so that it always shows the current amount of stock on hand |
|
|
Term
|
Definition
| an inventory system in which the item is deducted from inventory as it is sold or dispensed |
|
|
Term
|
Definition
| minimum and maximum stock levels which determine when a reorder is placed and for how much |
|
|
Term
| what is Backer Cells and example of |
|
Definition
| an automated counting/filling device |
|
|
Term
|
Definition
| robotic dispensing machine |
|
|
Term
| what is Homerus and example of |
|
Definition
| a centralized robotic unit dose dispensing device |
|
|
Term
| Automated dispensing system |
|
Definition
| a system in which medications are dispensed upon confirmation of an order communicated from a centralized computer system at their point-of-use |
|
|
Term
| Material Safety Data Sheet (MSDS) |
|
Definition
| OSHA required notices on hazardous substances which provide hazard handling clean-up, and first aid info |
|
|
Term
|
Definition
| a package containing a single dose of a medication |
|
|
Term
| what should the temperature of refrigeration usually be |
|
Definition
|
|
Term
|
Definition
|
|
Term
| What dose each Unit-dose package contain |
|
Definition
| name of the drug, strength, and the expiration date |
|
|
Term
| Pharmacy benefit managers |
|
Definition
| companies that administer drug benefit programs |
|
|
Term
|
Definition
| the resolution of prescription coverage through the communication of the pharmacy computer with the third party computer |
|
|
Term
|
Definition
| an agreement for cost-sharing btwn the insurer and the insured |
|
|
Term
|
Definition
| the portion of the price of medication that the patient is required to pay |
|
|
Term
| maximum allowable cost(MAC) |
|
Definition
| the maximum price per tablet an insurer or PBM will pay for the given product |
|
|
Term
|
Definition
| co-pays that have two prices: one for generic and one for brand medications |
|
|
Term
|
Definition
| a set amount that must be paid by the patient for each benefit period before the insurer will cover additional expences |
|
|
Term
| prescription drug benefit cards |
|
Definition
| cards that contain third party billing information for prescription drug purchases |
|
|
Term
|
Definition
| categories of medications that are covered by third party plans |
|
|
Term
|
Definition
| a network of providers for which costs are covered inside but not outside the network |
|
|
Term
|
Definition
| a network of providers where the patients primary care physician must be a member and costs outside the network may be partially reimbursed |
|
|
Term
|
Definition
| a network of providers where costs outside the network may be partially reimbursed and the patients primary care physician need not be a member |
|
|
Term
| patient assistance programs |
|
Definition
| manufacturer sponsored prescription drug programs for the needy |
|
|
Term
|
Definition
| basically covers inpatient hospital expenses for patients who meet certain conditions |
|
|
Term
|
Definition
| Basically covers Drs services as well as some other medical services not covered by part A |
|
|
Term
|
Definition
| a standard claim form accepted by many insurers |
|
|
Term
|
Definition
| The standard form used by health care providers such as physicians to bill for services |
|
|
Term
|
Definition
| The standard form used by health care providers to apply for a National Ptovider Identifier |
|
|
Term
| Medication Therapy Management Services |
|
Definition
| services provided to some medicare beneficiaries who are enrolled in Medicare Part D and who are taking multiple medications or have certain diseases |
|
|
Term
|
Definition
| third party programs from Medicare Part D |
|
|
Term
|
Definition
| individually owned local pharmacies |
|
|
Term
|
Definition
| regional or national pharmacy chains such as CVS |
|
|
Term
| Mass Merchandiser Pharmacies |
|
Definition
| regional or national mass merchandise chains such as target |
|
|
Term
|
Definition
| the difference btwn the retailers purchase price and their sale price |
|
|
Term
|
Definition
| the price of a unit of medication such as one ounce of a liquid cold remedy |
|
|
Term
|
Definition
| a pharmacy located in a hospital which services only those patients in the hospital and its ancillary areas |
|
|
Term
|
Definition
| a branch of the in-patient pharmacy responsible for preparing dispensing and monitoring medication for specific patient areas |
|
|
Term
|
Definition
| the main in-patient pharmacy in a hospital that has pharmacy satellites it is the place where most of the hospitals medications are prepared and stored |
|
|
Term
|
Definition
| a pharmacy attached to a hospital which services patients who have left the hospital or who are visiting doctors in a hospital outpatient clinic |
|
|
Term
|
Definition
| preparation of large quantities of unit-dose oral solutions/suspensions or small volume parenterals for future use |
|
|
Term
|
Definition
| a record of medications that are compounded in the pharmacy for non-specific patients. information must include a list of all the ingredients amounts used manufacturer lot numbers and expiration dates of each specific ingredient |
|
|
Term
|
Definition
| addition of water or other diluent to commercially made drug bottles or vials in order to make a solution or suspension from a pre-made powder form of the drug. this may include oral or parental products |
|
|
Term
|
Definition
| medications which must be prepared following a specific recipe or formula usually because they are not available commercially |
|
|
Term
|
Definition
| a package containing the amount of a drug required for one dose |
|
|
Term
|
Definition
| a small volume parenteral that will be added into or "piggybacked" into a large volume Parenteral |
|
|
Term
|
Definition
| another term for an antagonist drug because antagonists block the action of neurotransmitters |
|
|
Term
|
Definition
| another term for agonist because agonists imitate or mimic the action of the neurotransmitter |
|
|
Term
|
Definition
|
|
Term
|
Definition
| an antiviral used for HIV and Hepatitis C that blocks the enzyme responsible for viral replication |
|
|
Term
|
Definition
| drugs that reduce the oxygen demands of the heart muscle -olol |
|
|
Term
|
Definition
| drugs that relax the heart by reducing heart conduction -pine |
|
|
Term
|
Definition
| decrease blood pressure by decreasing blood volume |
|
|
Term
|
Definition
| relax blood vessels -pril -sartan |
|
|
Term
|
Definition
| relax and expand the blood vessels |
|
|
Term
|
Definition
| used to treat cardiac related chest pain resulting from ischemic heart disease |
|
|
Term
|
Definition
| used to treat irregular heart rhythms |
|
|
Term
|
Definition
| used to lower high levels of cholesterol that can lead to blocked blood vessels |
|
|
Term
|
Definition
| used to reduce a sustained elevation in blood pressure |
|
|
Term
|
Definition
|
|
Term
|
Definition
| prevent formation of blood clots |
|
|
Term
|
Definition
| act to increase blood pressure |
|
|
Term
|
Definition
| when a compound breaks down and separates into smaller components |
|
|
Term
|
Definition
| a substance that in solution forms ions that conduct an electrical current |
|
|
Term
|
Definition
| the fluid outside the bodys individual cells found in plasma and tissue fluid |
|
|
Term
|
Definition
| Treat nausea and vomiting |
|
|
Term
|
Definition
| drugs used to treat anemia |
|
|
Term
|
Definition
| drugs the prevent excessive bleeding |
|
|
Term
|
Definition
| drugs used for minor bleeding when sutures are not apporpiate |
|
|
Term
|
Definition
| a painful inflammatory condition in which excess uric acid accumulates in the joints |
|
|
Term
|
Definition
| a chronic and often progressive inflammatory condition with symptoms that include swelling feelings of warmth and joint pain |
|
|
Term
|
Definition
| a disorder characterized by weight-bearing bone deterioration decreasing range of motion pain and deformity |
|
|
Term
|
Definition
| drugs used to treat gout that increase the elimination of uric acid |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| angiotensin receptor antagonists |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
